Atlas Trials

A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

Clinical trial NCT03666728 · TERMINATED

Trial details

NCT number
NCT03666728
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Neoplasms
Start date
2018-11-30
Primary completion
2020-03-11
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.